Analyst Ratings For AbbVie (NYSE:ABBV)
Today, Jefferies Group LLC raised its price target on AbbVie (NYSE:ABBV) to $115.00 per share.
There are 6 hold ratings, 10 buy ratings on the stock.
The current consensus rating on AbbVie (NYSE:ABBV) is Buy (Score: 2.63) with a consensus target price of $93.33 per share, a potential 2.52% upside.
Some recent analyst ratings include
- 10/11/2017-Cowen and Company Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
- 10/2/2017-Leerink Swann Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
- 10/1/2017-Credit Suisse Group Reiterated Rating of Neutral.
- 9/30/2017-Evercore ISI Reiterated Rating of Outperform.
- 9/28/2017-BMO Capital Markets Reiterated Rating of Hold.
Dividend information for AbbVie (NYSE:ABBV)
AbbVie (NYSE:ABBV) pays an annual dividend of Community Ranking: with a yield of 2.81% and an average dividend growth of 12.50% based on a 3 Year Average.
Dividend History for AbbVie (NYSE:ABBV)
- On 9/8/2017 AbbVie announced a Quarterly dividend of $0.64 2.94% with an ex dividend date of 10/12/2017 which will be payable on 11/15/2017.
- On 6/23/2017 AbbVie announced a quarterly dividend of $0.64 3.52% with an ex dividend date of 7/12/2017 which will be payable on 8/15/2017.
- On 2/17/2017 AbbVie announced a quarterly dividend of $0.64 4.14% with an ex dividend date of 4/11/2017 which will be payable on 5/15/2017.
- On 10/28/2016 AbbVie announced a quarterly dividend of $0.64 4.44% with an ex dividend date of 1/11/2017 which will be payable on 2/15/2017.
- On 9/12/2016 AbbVie announced a quarterly dividend of $0.57 3.56% with an ex dividend date of 10/12/2016 which will be payable on 11/15/2016.
- On 6/17/2016 AbbVie announced a quarterly dividend of $0.57 3.8% with an ex dividend date of 7/13/2016 which will be payable on 8/15/2016.
- On 2/19/2016 AbbVie announced a quarterly dividend of $0.57 4.2% with an ex dividend date of 4/13/2016 which will be payable on 5/16/2016.
Recent Insider Trading Activity For AbbVie (NYSE:ABBV)
AbbVie (NYSE:ABBV) has insider ownership of 0.23% and institutional ownership of 68.25%.
- On 9/28/2017 Robert A Michael, VP, sold 6,699 with an average share price of $88.00 per share and the total transaction amounting to $589,512.00. View SEC Filing
- On 9/11/2017 Azita Saleki-Gerhardt, SVP, sold 8,300 with an average share price of $85.02 per share and the total transaction amounting to $705,666.00. View SEC Filing
- On 8/7/2017 Richard A Gonzalez, Chairman, sold 193,131 with an average share price of $71.00 per share and the total transaction amounting to $13,712,301.00. View SEC Filing
- On 8/4/2017 Richard A Gonzalez, Chairman, sold 87,899 with an average share price of $71.02 per share and the total transaction amounting to $6,242,586.98. View SEC Filing
- On 8/3/2017 Richard A Gonzalez, CEO, sold 65,861 with an average share price of $71.00 per share and the total transaction amounting to $4,676,131.00. View SEC Filing
- On 7/31/2017 Edward J Rapp, Director, bought 4,000 with an average share price of $70.45 per share and the total transaction amounting to $281,800.00. View SEC Filing
- On 7/31/2017 Henry O Gosebruch, Insider, sold 18,000 with an average share price of $70.09 per share and the total transaction amounting to $1,261,620.00. View SEC Filing
Recent Trading Activity for AbbVie (NYSE:ABBV)
Shares of AbbVie closed the previous trading session at with shares trading hands.